The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys

BACKGROUND: Activation of the peroxisome proliferator-activated receptor gamma (PPAR-γ) has been proposed as a possible neuroprotective strategy to slow down the progression of early Parkinson's disease (PD). Here we report preclinical data on the use of the PPAR-γ agonist pioglitazone (Actos(®...

Descripción completa

Detalles Bibliográficos
Autores principales: Swanson, Christine R, Joers, Valerie, Bondarenko, Viktoriya, Brunner, Kevin, Simmons, Heather A, Ziegler, Toni E, Kemnitz, Joseph W, Johnson, Jeffrey A, Emborg, Marina E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166925/
https://www.ncbi.nlm.nih.gov/pubmed/21819568
http://dx.doi.org/10.1186/1742-2094-8-91

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166925/
https://www.ncbi.nlm.nih.gov/pubmed/21819568
http://dx.doi.org/10.1186/1742-2094-8-91

Ejemplares similares